1. Home
  2. BLFY vs GNFT Comparison

BLFY vs GNFT Comparison

Compare BLFY & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFY
  • GNFT
  • Stock Information
  • Founded
  • BLFY 1939
  • GNFT 1999
  • Country
  • BLFY United States
  • GNFT France
  • Employees
  • BLFY N/A
  • GNFT N/A
  • Industry
  • BLFY Commercial Banks
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BLFY Finance
  • GNFT Health Care
  • Exchange
  • BLFY Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • BLFY 224.0M
  • GNFT 202.6M
  • IPO Year
  • BLFY N/A
  • GNFT 2019
  • Fundamental
  • Price
  • BLFY $9.64
  • GNFT $3.83
  • Analyst Decision
  • BLFY Hold
  • GNFT Strong Buy
  • Analyst Count
  • BLFY 2
  • GNFT 1
  • Target Price
  • BLFY $11.00
  • GNFT $13.00
  • AVG Volume (30 Days)
  • BLFY 42.2K
  • GNFT 12.7K
  • Earning Date
  • BLFY 01-29-2025
  • GNFT 04-03-2025
  • Dividend Yield
  • BLFY N/A
  • GNFT N/A
  • EPS Growth
  • BLFY N/A
  • GNFT N/A
  • EPS
  • BLFY N/A
  • GNFT 0.47
  • Revenue
  • BLFY $40,694,000.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • BLFY N/A
  • GNFT $145.20
  • Revenue Next Year
  • BLFY $21.23
  • GNFT N/A
  • P/E Ratio
  • BLFY N/A
  • GNFT $8.08
  • Revenue Growth
  • BLFY N/A
  • GNFT 175.45
  • 52 Week Low
  • BLFY $7.90
  • GNFT $3.35
  • 52 Week High
  • BLFY $11.48
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • BLFY 43.92
  • GNFT 48.44
  • Support Level
  • BLFY $9.75
  • GNFT $3.69
  • Resistance Level
  • BLFY $10.24
  • GNFT $4.03
  • Average True Range (ATR)
  • BLFY 0.21
  • GNFT 0.16
  • MACD
  • BLFY -0.01
  • GNFT -0.00
  • Stochastic Oscillator
  • BLFY 18.92
  • GNFT 24.59

About BLFY Blue Foundry Bancorp

Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: